Rebus Holdings Inc (RBSH)

[powerbattles]

LICENSING DEAL OR NOT?... ONE CAN'T REFUSES TO ADMIT THE TRUTH EXISTENCE OF MISAGARGIN USED IN A NEW PATENT FOR THE TREATMENT OF GLOBALASTOMA.

MediciNova Receives Notice of Allowance for Second Patent Covering MN-166 (ibudilast) for the Treatment of Glioblastoma

https://www.biospace.com/article/releases/medicinova-receives-notice-of-allowance-for-second-patent-covering-mn-166-ibudilast-for-the-treatment-of-glioblastoma/